跳至主要内容
临床试验/ACTRN12616000187448
ACTRN12616000187448招募中未知

Does bright light therapy improve sleep, reduce fatigue and improve quality of life in children (3-9 years old) with acute lymphoblastic leukaemia during maintenance therapy

isa Walter0 个研究点目标入组 80 人开始时间: 2016年2月12日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
3 Years 至 9 Years(—)
性别
All

入选标准

  • Children 3 to 9 years of age
  • Undergoing maintenance treatment for acute lymphoblastic leukaemia
  • White cell count less than 50,000 cells per microliter
  • Favourable cytogenetics, i.e. no extreme hypodiploidy with < 44 chromosomes/cell; MLL gene rearrangement; Philadelphia chromosome positivity; Internal amplification of chromosome 21
  • No cerebrospinal disease

排除标准

  • Children who are blind
  • Have a history of diagnosed retinal problems
  • On photo-sensitive medication, such as azole anti-fungal medication (risk of photosensitivity
  • On medications which alter/induce sleep
  • On psychotropic medications
  • Non-English speaking and/or non-English speaking parents
  • Have pre-existing developmental disabilities
  • Have epilepsy or migraines
  • Wear tinted glasses
  • Are in foster care or with documented protective services involvement.

研究者

发起方
isa Walter

相似试验